Page 34 - Jon Hamilton News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Three experts have now resigned from a Food and Drug Administration advisory committee after the agency approved an Alzheimer's drug called Aduhelm

Stroke patients who are struggling to regain the use of a hand will soon have access to a new FDA-cleared device that uses signals from the undamaged part of the brain to retrain the injured limb.

Jon Hamilton Jon Hamilton is a correspondent for NPR's Science Desk. Currently he focuses on neuroscience and health risks. In 2014, Hamilton went to Liberia as part of the NPR team that covered Ebola. The team received a Peabody Award for its coverage. Following the 2011 earthquake and tsunami in Japan, Hamilton was part of NPR's team of science reporters and editors who went to Japan to cover the crisis at the Fukushima Dai-ichi nuclear power plant. Hamilton contributed several pieces to the Science Desk series "The Human Edge," which looked at what makes people the most versatile and power...

Copyright 2021 NPR. To see more, visit https://www.npr.org. MARY LOUISE KELLY, HOST: An experimental drug appears to help people with a genetic disorder called Fragile X syndrome. Fragile X is the most common inherited cause of intellectual disabilities and autism. NPR's Jon Hamilton reports that a drug intended for Alzheimer's patients appears to ease some of the symptoms. JON HAMILTON, BYLINE: Alzheimer's and Fragile X both affect a substance that helps transmit messages inside cells. A small company called Tetra Therapeutics have been working on an Alzheimer's drug that manipulates this ...

A pharmacist prepares to administer the AstraZeneca COVID-19 vaccine at a community vaccination center in London on Friday. Image: Chris Jackson/Getty Images Updated on March 15 at 12:05 p.m. ET France, Germany, the Netherlands and Ireland have joined a number of other European nations in temporarily suspending administration of a COVID-19 vaccine made by AstraZeneca after reports of abnormal blood clotting in several people. Germany's health minister Jens Spahn announced Monday that the country would suspend administering the AstraZeneca vaccine. Spahn said it was a precautionary measure fol...